Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers. - Kreuter, Alexander; Rasokat, Heinrich; Klouche, Mariam; Esser, Stefan; Bader, Armin; Gambichler, Thilo; Altmeyer, Peter; Brockmeyer, Norbert H. (Cancer Investigation, 2005)